Research ArticleNew Research, Cognition and Behavior

Dopaminergic Drug Effects on Probability Weighting during Risky Decision Making

Karita E. Ojala, Lieneke K. Janssen, Mahur M. Hashemi, Monique H. M. Timmer, Dirk E. M. Geurts, Niels P. ter Huurne, Roshan Cools and Guillaume Sescousse
eNeuro 16 March 2018, 5 (2) ENEURO.0330-18.2018; https://doi.org/10.1523/ENEURO.0330-18.2018

Article Information

DOI 
https://doi.org/10.1523/ENEURO.0330-18.2018
PubMed 
29632870
Published By 
Society for Neuroscience
History 
  • Received September 22, 2017
  • Revision received February 23, 2018
  • Accepted February 26, 2018
  • Published online March 16, 2018.
Copyright & Usage 
Copyright © 2018 Ojala et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Author Information

  1. Karita E. Ojala1,
  2. Lieneke K. Janssen1,
  3. Mahur M. Hashemi1,
  4. Monique H. M. Timmer1,2,
  5. Dirk E. M. Geurts1,3,
  6. Niels P. ter Huurne1,4,
  7. Roshan Cools1,3 and
  8. Guillaume Sescousse1
  1. 1Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, 6525 HR The Netherlands
  2. 2Department of Neurology, Radboud University Medical Centre, Nijmegen, 6525 EX The Netherlands
  3. 3Department of Psychiatry, Radboud University Medical Centre, Nijmegen, 6525 GA The Netherlands
  4. 4 Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, 6525 GC The Netherlands
  1. Correspondence should be addressed to either of the following: Karita E. Ojala, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric University Hospital, University of Zurich, Lenggstrasse 31, 8032 Zurich, Switzerland, E-mail: karita.ojala{at}uzh.ch; or Guillaume Sescousse, Donders Centre for Cognitive Neuroimaging, PO Box 9101, 6500 HB Nijmegen, The Netherlands, E-mail: g.sescousse{at}donders.ru.nl.

  • K. E. Ojala’s present address: Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric University Hospital 8032 Zurich; Neuroscience Centre Zurich, University of Zurich, 8057 Zurich, Switzerland.

  • L. K. Janssen’s present address: Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences; Leipzig University Medical Center, IFB Adiposity Diseases, 04103 Leipzig, Germany.

View Full Text

Author contributions

  1. Author contributions: R.C. and G.S. designed research; L.K.J., M.M.H., M.H.M.T., D.E.M.G., N.P.t.H., and G.S. performed research; K.E.O. and G.S. analyzed data; K.E.O, R.C., and G.S. wrote the paper.

  • K. E. Ojala’s present address: Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric University Hospital 8032 Zurich; Neuroscience Centre Zurich, University of Zurich, 8057 Zurich, Switzerland.

  • L. K. Janssen’s present address: Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences; Leipzig University Medical Center, IFB Adiposity Diseases, 04103 Leipzig, Germany.

Disclosures

  • The authors declare no competing financial interests.

  • G.S. was supported by a Veni grant from the Netherlands Organisation for Scientific Research (NWO).

Funding

  • Netherlands Organisation for Scientific Research (NWO)

Other Version

Online Impact

 

Article usage

Article usage: March 2018 to June 2025

AbstractFullPdf
Mar 20185750143
Apr 2018429223129
May 20181217930
Jun 2018636947
Jul 2018674423
Aug 2018274732
Sep 2018204214
Oct 20183410517
Nov 20182219224
Dec 20181819012
Total 20181376991471
Jan 2019618118
Feb 20191021216
Mar 20191013215
Apr 201912789
May 201944012
Jun 201974212
Jul 20198439
Aug 201954912
Oct 201910327
Nov 20197334
Dec 201943618
Total 201983878132
Jan 202033413
Feb 202022218
Mar 202052713
May 202022512
Jun 20202276
Jul 20200269
Aug 20203144
Sep 202054615
Oct 20202685
Nov 20203409
Dec 202057310
Total 202032402114
Jan 20212447
Feb 20211548
Mar 202135319
Apr 202114510
May 202124111
Jun 202105214
Jul 202115311
Aug 202114112
Sep 202114716
Oct 202115449
Nov 202115741
Dec 202105116
Total 202114592214
Jan 202224820
Feb 20223316
Mar 202224321
Apr 202254013
May 202204219
Jun 20222448
Jul 202203113
Aug 202206221
Sep 202223021
Oct 202248015
Nov 202203318
Dec 202234217
Total 202223526192
Jan 202314611
Feb 202313312
Mar 20230348
Apr 20230385
May 20230328
Jun 202323915
Jul 2023165529
Aug 202375222
Sep 20235377
Oct 202355814
Nov 202333915
Dec 202365822
Total 202346521168
Jan 20240416
Feb 20249416
Mar 202444414
Apr 2024105217
May 2024519011
Jun 202466119
Jul 202446818
Aug 202434720
Sep 20242649
Oct 20242539
Nov 2024115218
Dec 202455013
Total 202461763160
Jan 202535717
Feb 202537510
Mar 202536412
Apr 202525910
May 202525810
Jun 202564611
Total 20251935970
Total165450321521
Back to top

In this issue

eneuro: 5 (2)
eNeuro
Vol. 5, Issue 2
March/April 2018
Email
Print
View Full Page PDF
Citation Tools
Respond to this article
Dopaminergic Drug Effects on Probability Weighting during Risky Decision Making
Karita E. Ojala, Lieneke K. Janssen, Mahur M. Hashemi, Monique H. M. Timmer, Dirk E. M. Geurts, Niels P. ter Huurne, Roshan Cools, Guillaume Sescousse
eNeuro 16 March 2018, 5 (2) ENEURO.0330-18.2018; DOI: 10.1523/ENEURO.0330-18.2018
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Subjects